全文获取类型
收费全文 | 3844篇 |
免费 | 559篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 139篇 |
儿科学 | 180篇 |
妇产科学 | 39篇 |
基础医学 | 507篇 |
口腔科学 | 61篇 |
临床医学 | 487篇 |
内科学 | 1072篇 |
皮肤病学 | 77篇 |
神经病学 | 306篇 |
特种医学 | 304篇 |
外科学 | 508篇 |
综合类 | 43篇 |
一般理论 | 3篇 |
预防医学 | 197篇 |
眼科学 | 136篇 |
药学 | 186篇 |
中国医学 | 1篇 |
肿瘤学 | 201篇 |
出版年
2023年 | 56篇 |
2021年 | 45篇 |
2020年 | 103篇 |
2019年 | 31篇 |
2018年 | 114篇 |
2017年 | 94篇 |
2016年 | 97篇 |
2015年 | 83篇 |
2014年 | 137篇 |
2013年 | 174篇 |
2012年 | 138篇 |
2011年 | 141篇 |
2010年 | 127篇 |
2009年 | 157篇 |
2008年 | 144篇 |
2007年 | 153篇 |
2006年 | 135篇 |
2005年 | 95篇 |
2004年 | 95篇 |
2003年 | 77篇 |
2002年 | 76篇 |
2001年 | 107篇 |
2000年 | 106篇 |
1999年 | 89篇 |
1998年 | 100篇 |
1997年 | 112篇 |
1996年 | 103篇 |
1995年 | 81篇 |
1994年 | 70篇 |
1993年 | 81篇 |
1992年 | 68篇 |
1991年 | 54篇 |
1990年 | 70篇 |
1989年 | 97篇 |
1988年 | 75篇 |
1987年 | 82篇 |
1986年 | 61篇 |
1985年 | 63篇 |
1984年 | 43篇 |
1983年 | 40篇 |
1982年 | 44篇 |
1981年 | 44篇 |
1980年 | 36篇 |
1979年 | 62篇 |
1978年 | 35篇 |
1977年 | 56篇 |
1976年 | 39篇 |
1975年 | 49篇 |
1974年 | 48篇 |
1973年 | 37篇 |
排序方式: 共有4447条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
A number of vitamin D3 metabolites inhibit benzodiazepine- and dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells. The inhibition is dose dependent and occurs at nM concentrations. The order of potency of these compounds is 1,25-dihydroxycholecalciferol greater than 1,25,26-trihydroxycholecalciferol greater than 1,24R,25-trihydroxycholecalciferol greater than 1 alpha-hydroxycholecalciferol greater than 24R,25-dihydroxycholecalciferol greater than 25S,26-dihydroxycholecalciferol. The inhibition is maximal when the vitamin D3 analogs are added together with the inducer, and becomes progressively decreased with delayed addition. These results suggest that the vitamin D3 metabolites may play a regulatory role in erythropoiesis. 相似文献
5.
Human and animal studies have implicated dopamine in appetite regulation, and family studies have shown that BMI has a strong genetic component. Dopamine availability is controlled largely by three enzymes: COMT, MAOA and MAOB, and by the dopamine transporter SLC6A3, and each gene has a well-characterized functional variant. Here we look at these four functional polymorphisms together, to investigate how heritable variation in dopamine levels influences the risk of obesity in a cohort of 1150, including 240 defined as obese (BMI ≥ 30). The COMT and SLC6A3 polymorphisms showed no association with either weight, BMI or obesity risk. We found, however, that both MAOA and MAOB show an excess of the low-activity genotypes in obese individuals ( MAOA: χ2 = 15.45, p = 0.004; MAOB: χ2 = 8.05, p = 0.018). Additionally, the MAOA genotype was significantly associated with both weight (p = 0.0005) and BMI (p = 0.001). When considered together, the 'at risk genotype' - low activity genotypes at both the MAOA and MAOB loci - shows a relative risk for obesity of 5.01. These results have not been replicated and, given the experience of complex trait genetics, warrant caution in interpretation. In implicating both the MAOA and MOAB variants, however, this study provides the first indication that dopamine availability (as opposed to other effects of MAOA) is involved in human obesity. It is therefore a priority to assess the associations in replication datasets. 相似文献
6.
7.
8.
Usha Chinappen-Horsley Glen M Blake Ignac Fogelman Tim D Spector 《BMC musculoskeletal disorders》2007,8(1):113
Background
Skeletal ratios and bone lengths are widely used in anthropology and forensic pathology and hip axis length is a useful predictor of fracture. The aim of this study was to show that skeletal ratios, such as length of femur to height, could be accurately measured from a DXA (dual energy X-ray absorptiometry) image. 相似文献9.
10.